Zentalis Pharmaceuticals, Inc. (ZNTL) Misses Q2 EPS by 82c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q2 EPS of ($1.85), $0.82 worse than the analyst estimate of ($1.03).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Brinker Int'l (EAT) PT Lowered to $240 at DA Davidson Ahead of Analyst Day
• Rent the Runway (RENT) Reports Q2 Loss of $0.38/sh